TG Therapeutics, Inc. (TGTX)
54.30
+0.37
(+0.69%)
USD |
NASDAQ |
Aug 31, 16:00
54.09
-0.21
(-0.39%)
After-Hours: 07:17
TG Therapeutics Total Long Term Debt (Quarterly) : 752.53M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 752.53M |
| March 31, 2026 | 751.74M |
| December 31, 2025 | 252.67M |
| September 30, 2025 | 252.65M |
| June 30, 2025 | 252.62M |
| March 31, 2025 | 252.59M |
| December 31, 2024 | 252.56M |
| September 30, 2024 | 252.58M |
| June 30, 2024 | 111.23M |
| March 31, 2024 | 110.29M |
| December 31, 2023 | 109.35M |
| September 30, 2023 | 108.43M |
| June 30, 2023 | 107.50M |
| March 31, 2023 | 106.58M |
| December 31, 2022 | 81.48M |
| September 30, 2022 | 80.62M |
| June 30, 2022 | 78.92M |
| March 31, 2022 | 77.57M |
| December 31, 2021 | 77.61M |
| September 30, 2021 | 26.02M |
| June 30, 2021 | 33.34M |
| March 31, 2021 | 40.48M |
| December 31, 2020 | 19.07M |
| September 30, 2020 | 39.95M |
| June 30, 2020 | 39.71M |
| Date | Value |
|---|---|
| March 31, 2020 | 39.53M |
| December 31, 2019 | 39.38M |
| September 30, 2019 | 38.22M |
| June 30, 2019 | 36.72M |
| March 31, 2019 | 36.60M |
| December 31, 2018 | 0.067M |
| September 30, 2018 | 0.091M |
| June 30, 2018 | 0.21M |
| March 31, 2018 | 0.224M |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.1822M |
| June 30, 2017 | 0.1526M |
| March 31, 2017 | 0.1747M |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.1171M |
| June 30, 2016 | 0.0906M |
| March 31, 2016 | 0.1529M |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.1817M |
| June 30, 2015 | 0.2954M |
| March 31, 2015 | 0.2722M |
| December 31, 2014 | 0.2752M |
| September 30, 2014 | 0.1831M |
| June 30, 2014 | 0.1592M |
| March 31, 2014 | 0.1156M |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Krystal Biotech, Inc. | 7.045M |
| MAIA Biotechnology, Inc. | 0.00 |
| Alnylam Pharmaceuticals, Inc. | 2.942B |
| BioMarin Pharmaceutical, Inc. | 4.186B |
| Cytokinetics, Inc. | 1.250B |